Biomerica (BMRA) Change in Accured Expenses (2010 - 2026)
Biomerica (BMRA) reported Change in Accured Expenses of $63000.0 for Q1 2026, down 74.49% on a YoY basis from $247000.0 in Q1 2025, and up 152.5% sequentially from -$120000.0 in Q4 2025.
Biomerica (BMRA) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Biomerica (BMRA) has 17 years of Change in Accured Expenses data on file, last reported at $63000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Accured Expenses fell 74.49% year-over-year to $63000.0; the trailing twelve-month figure through Feb 2026 stood at -$470000.0 (down 422.22% YoY), and the FY2025 full-year result was -$466000.0, down 1036.59% from the prior year.
- Change in Accured Expenses climbed to $63000.0 in Q1 2026, from -$120000.0 in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $247000.0 in Q1 2025 to a low of -$423000.0 in Q2 2025.
- A 5-year average of -$31319.5 and a median of -$29000.0 in 2023 frame the typical range for Change in Accured Expenses.
- Peak annual rise in Change in Accured Expenses reached 228.43% in 2023, while the deepest fall reached 8000.0% in 2023.
- Tracing BMRA's Change in Accured Expenses over 5 years: stood at -$1000.0 in 2022, then sank by 8000.0% to -$81000.0 in 2023, then sank by 197.53% to -$241000.0 in 2024, then surged by 50.21% to -$120000.0 in 2025, then soared by 152.5% to $63000.0 in 2026.
- Business Quant data shows BMRA's Change in Accured Expenses at $63000.0 in Q1 2026, -$120000.0 in Q4 2025, and $10000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 123.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 145.10 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 21.07 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Biomerica | 4.85 Mn | 3.51 Mn | -44,000.00 | 63,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 63,000.00 |
| Feb 28, 2026 | 63,000.00 |
| Nov 30, 2025 | -120,000.00 |
| Nov 30, 2025 | -120,000.00 |
| Aug 31, 2025 | 10,000.00 |
| Aug 31, 2025 | 10,000.00 |
| May 31, 2025 | -423,000.00 |
| May 31, 2025 | -423,000.00 |
| Feb 28, 2025 | 247,000.00 |
| Feb 28, 2025 | 247,000.00 |
| Nov 30, 2024 | -241,000.00 |
| Nov 30, 2024 | -241,000.00 |
| Aug 31, 2024 | -49,000.00 |
| Aug 31, 2024 | -49,000.00 |
| May 31, 2024 | -47,000.00 |
| May 31, 2024 | -47,000.00 |
| Feb 29, 2024 | 116,000.00 |
| Feb 29, 2024 | 116,000.00 |
| Nov 30, 2023 | -81,000.00 |
| Nov 30, 2023 | -81,000.00 |